Applications published 16 November 2011

Published: 14-Dec-2011

Selected patent applications from the weekly European Patents Bulletin


  • Tellurium containing compounds for affecting males’ fertility following chemotherapy and/or radiotherapy
    Biomas 2385757*

  • Tellurium containing compounds for affecting females’ fertility following chemotherapy and/or radiotherapy
    Biomas 2385758*

  • Microbicidal compsns including activated nitrogenous compound and 1,4-bis (bromoacetoxy)-2-butene, and methods of using the same
    Buckman Laboratories International 2385759*

  • Inhibition of bacterial protein production by polyvalent oligonucleotide modified nanoparticle conjugates
    Northwestern University 2385760*

  • Methods for treating vascular leak syndrome
    Akebia Therapeutics 2385763*

  • Improved pharmaceutical formulation
    Egis Gyógyszergyár Nyilvánosan Müködö 2385821*

  • Pharmaceutical compsn containing malathion and a volatile cyclic silicone
    Pierre Fabre Dermo-Cosmétique 2385822*

  • Dual release pharmaceutical suspension
    Panacea Biotec 2385823*

  • Nanoparticle pharmaceutical formulations
    Pharmanova 2385824*

  • Factor VIII formulations
    Baxter International; University of Connecticut 2385825*

  • Methods and materials for delivering bile acids
    Mayo Foundation for Medical Education and Research 2385826*

  • Pharmaceutical dosages delivery system
    Proteus Biomedical 2385827*

  • High-throughput production of ingestible event markers
    Proteus Biomedical 2385828*

  • Pro-neurogenic compounds
    Board of Regents of the University of Texas System 2385829*

  • Treatment of diabetes in patients with inadequate glycaemic control despite metformin therapy comprising a DPP-IV inhibitor
    Boehringer Ingelheim International 2385830*

  • Small molecule inhibitors of NADS, NAMNAT and NMNAT
    The UAB Research Foundation 2385831*

  • Phosphoinositide 3-kinase inhibitors with a zinc binding moiety
    Curis 2385832*

  • Combination of a cyclosporine derivative and nucleosides for treating HCV
    Scynexis 2385833*

  • Use of deuterium oxide for treating viral diseases of the respiratory tract
    D2 Biosciences Group 2385834*

  • Use of deuterium oxide for treating viral diseases of the eye
    D2 Biosciences Group 2385835*

  • Compsns comprising probiotic and prebiotic components and mineral salts, with lactoferrin
    Pfizer Italia 2385837*

  • Cyclosporine derivatives for use in the treatment of HCV and HIV infection
    Scynexis 2385838*

  • Therapeutic compsns for treatment of corneal disorders
    The Schepens Eye Research Institute 2385839*

  • Materials and methods for the treatment of hypertension
    Vegenics 2385840*

  • Prevention and/or treatment of multiple organ dysfunction syndrome with interleukin-2
    Generon (Shanghai) 2385841*

  • CNA_B domain antigens in vaccines against gram-positive bacteria
    Novartis 2385842*

  • Treatment of mucositis with kallikrein inhibitors
    Dyax 2385843*

  • Complex comprising both heparin and binding proteins and heparin-hydroxyalkyl starch conjugates
    Octapharma 2385844*

  • Contrast media compsns
    GE Healthcare 2385845*

  • Medical implants and method for producing such an implant
    Acandis 2385846*

  • Implantable medical devices comprising bio-degradable alloys
    Bio DG 2385847*

  • Drug eluting medical device
    Invatec Technology Center 2385848*

  • Systems and methods for obtaining immunoglobulin from blood
    Baxter International; Baxter Healthcare 2385850*

  • Dosing device
    Sanofi 2385852*

  • Optimised intracranial catheters for convection-enhanced delivery of therapeutics
    Becton, Dickinson & Co 2385854*

  • Fluorine containing compounds and methods of use thereof
    President & Fellows of Harvard College 2385943*

  • Fluorine containing compounds and methods of use thereof
    President & Fellows of Harvard College 2385944*

  • Triazolo and tetrazolo pyrimidine derivatives as NHE inhibitors for treating COPD
    Bayer Pharma 2385945*

  • Derivatives of 6-cycloamino-2,3-dipyridinyl-imidazo[1,2-B]-pyridazine, preparation and therapeutic application thereof
    Sanofi 2385946*

  • Time-temperature indicator comprising indolenin-based spiropyrans
    BASF 2385947*

  • Fused thiazo and oxazolo pyrimidinones
    Torrent Pharmaceuticals 2385948*

  • Novel germanium complexes with amidine derivative ligand and process for preparing the same
    Techno Semichem 2385949*

  • Method for 2-sulphation of glycosides
    University of Washington 2385950*

  • Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections
    University College Cardiff Consultants; Inhibitex 2385951*

  • Method for selection of endothelial cell death inducers via netrin-1 and its applications
    Centre National de la Recherche Scientifique (C.N.R.S) 2385952*

  • Process for regulating immune response
    The UAB Research Foundation 2385953*

  • Complex and production process
    Hamlet Pharma 2385954*

  • Modified antibody compsns, methods of making and using thereof
    CytomX Therapeutics 2385955*

  • Sequence-specific large volume sample preparation method and assay Quiagen Gaithersburg 2385979*

  • Bacterial vaccines with cell wall-associated ceramide-like glycolipids and uses thereof
    The Albert Einstein College of Medicine of Yeshiva University 2385980*

  • Method for controlling streptococcus pneumoniae polysaccharide molecular weight using carbon
    Wyeth 2385981*

  • Carbonic anhydrase polypeptides and uses thereof
    Codexis 2385982*

  • Transaminase polypeptides
    Codexis 2385983*

  • Recombinant porcine chymotrypsin
    Nestec 2385984*

  • Processing of macronutrients
    Nestec 2385985*

  • Clay compsns
    Ipsen Pharma 2386289

  • Modulating drug release rate by controlling the kinetics of the pH transition of hydrogels
    Confluent Surgical 2386290

  • Vaginally administrable progesterone-containing tablets and method for preparing the same
    Ferring 2386291

  • Improvements relating to nanodispersions
    Iota NanoSolutions 2386292

  • Process for producing a solid dispersion of an active ingredient
    Abbott 2386293

  • Unitary pharmaceutical dosage form comprising Tenofovir DF Bristol-Myers Squibb & Gilead Sciences 2386294

  • Tablets with site time-controlled gastro-intestinal release of active ingredients Jagotec 2386295

  • New application forms for cineol
    Maria Clementine Martin Klosterfrau Vertriebsgesellschaft 2385296

  • Indigestible polymer: starch acetate-based film coatings for colon targeting
    Roquette Frères 2386297

  • Treatment of intestinal conditions
    Sylentis 2386298

  • 1-amino-alkylcyclohexane derivatives for the treatment of cochlear tinnitus
    Marz Pharma 2386299

  • Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalisation or of mortality in patients having a first recurrence of atrial fibrillation of atrial flutter
    Sanofi 2386300

  • Pharmaceutical compsn of levoamlodipine or pharmaceutically acceptable salts thereof
    Shihuda Pharmaceuticals Group 2386301

  • A controlled release pharmaceutical dosage form of trimetazide and processes for the preparation thereof
    Ranbaxy Laboratories 2386302

  • Eslicarbazepine acetate and methods of use
    Bial-Portela 2386303

  • Selective estrogen receptor modulator in combination with dehydroepiandrosterone (DHEA) or analogues
    Endorecherche 2386304

  • Selective estrogen receptor modulator in combination with dehydroepiandrosterone (DHEA) or analogues
    Endorecherche 2386305

  • Pharmaceutical agent having long-lasting effect of treating arthritic disorders
    Seikagaku 2396306

  • Compsns for preventing and treating cancer containing egg whites combined with blue vitriol
    Choi, Eun 2386307

  • Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
    Da Volterra 2386308

  • Bulbene frutescens gel
    Cremer Oleo 2386309

  • Compsns for improving lipid metabolism
    NRL Pharma 2386311

  • Intrathecal and intratumoral superantigens to treat malignant disease
    Terman, David 2386312

You may also like